by Cell and gene therapies are transforming modern medicine, but delivering these therapies safely is far more complicated than transporting conventional pharmaceutical products. Many cell and gene therapies are highly sensitive to temperature changes, require strict chain-of-identity and chain-of-custody controls, and may need specialized cryogenic packaging and real-time monitoring.
That makes the choice of a logistics partner a critical part of a successful cell and gene therapy program.
Why Cell and Gene Therapy Logistics Is Different
Traditional pharmaceutical logistics generally follows a relatively predictable supply chain. Cell and gene therapies can involve a much more complicated journey.
For example, an autologous cell therapy may involve:
Patient → Cell collection → Specialized transportation → Manufacturing → Quality testing → Cryogenic shipment → Treatment center → Patient
Every step needs to be carefully coordinated.
According to Towards Healthcare, cell and gene therapy logistics encompasses transportation, storage, distribution, tracking, packaging, and supply-chain management for highly sensitive products such as CAR-T cells, hematopoietic stem cells, viral therapies, and other advanced therapy medicinal products.
The logistics provider therefore needs expertise in more than simply moving a package from one location to another.
Top Courier Companies for Cell and Gene Logistics
1. Cryoport
Cryoport is one of the most prominent names in cell and gene therapy logistics. Towards Healthcare identifies the company among the leading players in both cell and gene therapy logistics and cold-chain logistics.
Its focus on specialized life-science supply chains makes it particularly relevant for therapies requiring temperature-controlled and cryogenic transportation.
Towards Healthcare also reported a 2024 strategic partnership between Cryoport and Minaris Regenerative Medicine to provide integrated logistics and manufacturing services for regenerative medicine products.
This type of integrated model is becoming increasingly important as cell and gene therapies move from clinical development toward commercial availability.
2. Marken
Marken, part of UPS, is another leading specialty logistics provider identified by Towards Healthcare.
The company appears prominently across the cell and gene therapy logistics value chain, including R&D, clinical trials, regulatory activities, and patient support services.
For advanced therapies, this type of specialized infrastructure can help pharmaceutical and biotechnology companies manage complex shipments while maintaining visibility throughout the logistics process.
3. World Courier
World Courier is another major player in the cell and gene therapy logistics landscape.
Towards Healthcare identifies World Courier among the key companies involved in cell and gene therapy cold-chain logistics and broader supply-chain solutions.
Its role is particularly relevant to temperature-sensitive pharmaceutical and clinical-trial shipments, where maintaining product integrity throughout transportation is essential.
4. DHL Life Sciences & Healthcare
DHL has a significant presence across global life-science logistics and is included by Towards Healthcare among the leading cell and gene therapy logistics providers.
The company is also identified among the leading providers of cell and gene therapy cold-chain logistics.
Towards Healthcare reported that DHL Group announced a €2 billion strategic investment over five years in July 2025 to strengthen its life sciences and healthcare logistics capabilities.
For pharmaceutical and biotechnology companies expanding internationally, global logistics infrastructure can be particularly valuable.
5. FedEx
FedEx is another major logistics company participating in the specialized healthcare and cell and gene therapy supply chain.
Towards Healthcare lists FedEx Custom Critical Healthcare Solutions among the key players in cell and gene therapy cold-chain logistics.
FedEx’s inclusion reflects the increasing role of major transportation providers in supporting specialized healthcare shipments alongside dedicated life-science logistics companies.
Other Important Cell and Gene Logistics Providers
The competitive landscape extends well beyond the five companies above.
Towards Healthcare also identifies:
- Thermo Fisher Scientific / Patheon
- Catalent
- Lonza
- BioLife Solutions
- Brooks Life Sciences
- TrakCel
- Be The Match BioTherapies
- QuickSTAT
- Biocair
- United Parcel Service
- McKesson Specialty Health
- Aramex Life Science Logistics
- Peli BioThermal
- SAVSU Technologies
as participants in the cell and gene therapy logistics ecosystem.
Some of these companies focus primarily on transportation, while others contribute through cold-chain technology, packaging, supply-chain software, storage, or specialized healthcare services.
Towards Healthcare estimates that the cell and gene therapy cold-chain logistics market will increase from USD 2.19 billion in 2025 to approximately USD 9.37 billion by 2035, representing a 15.64% CAGR from 2026 to 2035.
This growth reflects the increasing need for reliable logistics infrastructure as advanced therapies become more widely developed and commercialized.
What Should a Cell and Gene Therapy Courier Provide?
Choosing a courier for cell and gene therapies requires a different evaluation process than selecting a conventional pharmaceutical shipping provider.
Temperature Control
Cell and gene therapies can require highly controlled temperature conditions. Towards Healthcare highlights the importance of ultra-low and cryogenic transportation for these products.
Specialized packaging and cryogenic shipping systems can help maintain product stability throughout transportation.
Real-Time Monitoring
Visibility is another critical requirement.
Advanced logistics systems can monitor shipments and provide information about location, temperature, and other conditions during transit.
Towards Healthcare identifies smart tracking and monitoring systems as important areas of development within the cell and gene therapy cold-chain logistics value chain.
Chain of Identity and Chain of Custody
For personalized cell therapies, particularly autologous therapies, ensuring that the right biological material reaches the right patient is essential.
A logistics provider needs systems capable of supporting secure identification, tracking, and documentation throughout the journey.
Specialized Packaging
Packaging must be designed around the characteristics of the therapy.
Cryogenic containers, thermal protection, temperature monitoring, and validated packaging solutions can all play important roles in protecting sensitive products during transportation.
Global Reach
Clinical trials and commercial treatment programs increasingly operate across multiple countries.
A logistics provider with international infrastructure can help coordinate shipments across different geographic and regulatory environments.
Why Specialty Couriers Are Becoming More Important
The expansion of cell and gene therapy pipelines is creating new logistics challenges.
Unlike conventional medicines, these therapies may involve:
- Patient-specific materials
- Time-sensitive transportation
- Cryogenic storage
- Multiple manufacturing locations
- Complex return shipments
- Strict documentation
- Temperature monitoring
- Specialized packaging
- Hospital and treatment-center coordination
Towards Healthcare reports that the transportation and shipments segment dominated the cell and gene therapy logistics market in 2024, while IT and orchestration software is expected to be the fastest-growing component through the forecast period.
This indicates that logistics is evolving from simple transportation toward a more connected and technology-enabled service.
The Role of Technology in Cell and Gene Logistics
Technology is becoming an important part of the modern cell and gene supply chain.
Digital platforms can help coordinate:
Manufacturing → Storage → Transportation → Tracking → Treatment Center → Patient
This is especially important for therapies where delays or temperature excursions can potentially compromise the product.
Towards Healthcare identifies companies such as TrakCel, Vineti, SAVSU Technologies, and Hypertrust Patient Data Care within the broader cell and gene therapy logistics ecosystem, demonstrating the growing importance of digital orchestration and data management.
North America Leads the Market
North America currently holds the leading position in cell and gene therapy cold-chain logistics, according to Towards Healthcare.
The region’s position is supported by its strong biotechnology and pharmaceutical ecosystem, advanced healthcare infrastructure, and growing number of cell and gene therapy approvals.
As more advanced therapies move into clinical trials and commercial treatment, demand for specialized logistics infrastructure is expected to increase.
What Does the Future Look Like?
The cell and gene therapy logistics industry is moving toward more integrated and digitally connected supply chains.
Future logistics models are likely to combine:
- Cryogenic transportation
- Smart packaging
- Real-time monitoring
- Digital chain-of-custody systems
- Supply-chain orchestration
- Specialized storage
- Patient coordination
- Global distribution networks
About Us
Pharma Geek is a part of Towards Healthcare Research & Consulting which is a global healthcare market research and consulting firm dedicated to helping businesses make informed decisions through reliable market intelligence and strategic insights. We serve pharmaceutical, biotechnology, medical device, AI in healthcare, cell and gene therapy, digital health, and life sciences organizations with in-depth market research, custom consulting, competitive analysis, and growth forecasts. Our team combines industry expertise with rigorous research to deliver clear, actionable insights that support market expansion, product strategy, investment decisions, and long-term business growth. From emerging innovations to established healthcare markets, we help organizations understand where the industry is today and where it’s headed tomorrow.
You can place an order or ask any questions, please feel free to contact us at [email protected]
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Visit Our Website: Towards Healthcare Research & Consulting – Expert Consulting Solutions & Research Reports
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium
